Skip to main content

Biomarin Pharmaceutical Inc

BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001048477

In the last 90 days, Biomarin Pharmaceutical Inc insiders filed 0 open-market purchases and 1 sale; 565 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; Viking Global Investors is the only superinvestor holding it.

Superinvestors holding BMRN, Q2 2026

1 superinvestor reports holding Biomarin Pharmaceutical Inc on Form 13F, worth $435.8M in total. Weight is Biomarin Pharmaceutical Inc's share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding BMRN in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
Viking Global InvestorsAndreas Halvorsen1.2%7,616,563$435.8MAdded+7.9%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of BMRN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+7.9%)
  2. Q1 2026

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+17.0%)
  3. Q4 2025

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−27.5%)
  4. Q3 2025

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−32.3%)
  5. Q2 2025

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+13.8%)
    Sold out
    Elliott Investment Management
  6. Q1 2025

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+2.8%)
  7. Q4 2024

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+7.8%)
  8. Q3 2024

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+38.1%)
    Sold out
    Soros Fund Management
  9. Q2 2024

    3 superinvestors holding at quarter end

    Added
    Viking Global Investors (+10.1%), Soros Fund Management (+0.1%)
  10. Q1 2024

    3 superinvestors holding at quarter end

    New
    Soros Fund Management
    Added
    Viking Global Investors (+31.2%), Elliott Investment Management (+16.7%)
    Sold out
    Third Point
  11. Q4 2023

    3 superinvestors holding at quarter end

    New
    Elliott Investment Management, Third Point
    Added
    Viking Global Investors (+16.0%)
    Sold out
    HHLR Advisors (Hillhouse)
  12. Q3 2023

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+1.4%)
    Reduced
    HHLR Advisors (Hillhouse) (−50.2%)
  13. Q2 2023

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+91.7%)
    Reduced
    HHLR Advisors (Hillhouse) (−25.8%)
  14. Q1 2023

    2 superinvestors holding at quarter end

    New
    HHLR Advisors (Hillhouse)
    Reduced
    Viking Global Investors (−58.9%)
  15. Q4 2022

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+3.4%)
  16. Q3 2022

    1 superinvestor holding at quarter end

    Added
    Viking Global Investors (+0.9%)
    Sold out
    ARK Invest
  17. Q2 2022

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+34.6%)
    Reduced
    ARK Invest (−4.5%)
  18. Q1 2022

    2 superinvestors holding at quarter end

    New
    ARK Invest
    Added
    Viking Global Investors (+30.7%)
  19. Q4 2021

    1 superinvestor holding at quarter end

    New
    Viking Global Investors
    Sold out
    Maverick Capital
  20. Q3 2021

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−10.0%)
  21. Q2 2021

    1 superinvestor holding at quarter end

    New
    Maverick Capital